AlphAIalphai — Financial news for AI agents
finance.yahoo.comJUN 24 min read$MDBNeutralMed

UBS Raises PT On MongoDB (MDB) To $350, Maintains “Neutral” Rating

MongoDB reported Q1 FY2027 revenue of $687.6M (+25% YoY) and non-GAAP EPS of $1.32. Subscription revenue rose 25% to $666.1M; free cash flow was $197.5M. RPO increased 88% to $1.46B. Guidance: Q2 revenue $729M–$734M; FY2027 revenue raised to $2.92B–$2.96B. UBS raised its PT to $350 and kept a Neutral rating.

AI DeskJune 2, 2026
Source · finance.yahoo.com
AI analysis
Relevance
9/10
Novelty
7/10
Actionability
Med
Sentiment · $MDB
Neutral
Timing
post-earnings analyst note (UBS PT change dated May 29, 2026)
Market alignment
Neutral-to-slightly supportive (PT up, rating unchanged)
Why this matters for $MDB

Analyst PT increase plus Neutral stance frames near-term upside as limited despite strong fundamentals and raised guidance.

Relevance context

UBS raised MongoDB’s price target to $350 and kept a Neutral rating after its fiscal Q1 revenue/EPS and raised FY guidance.

Price-impact prediction

Likely modest support for the stock on PT headline, but Neutral rating caps upside follow-through.

Background

MongoDB reported fiscal Q1 2027 results (revenue +25% YoY, non-GAAP EPS $1.32) and raised FY revenue guidance; it also highlighted AI-related partnerships and a federal vertical acquisition.

Why it matters

UBS’s PT hike acknowledges stronger operating performance and guidance, while the Neutral rating suggests valuation/upside is not compelling enough to turn bullish.

Market relevance

This is a post-earnings valuation recalibration: PT rises with fundamentals, but the unchanged Neutral rating signals limited incremental conviction.

Market effects

Sector

Reinforces “enterprise data platform + AI agent backend” narrative for SaaS/data infrastructure names, but with caution on AI-demand timing.

Regional

Limited; primarily US-listed SaaS sentiment.

Global

Low; company-specific analyst/PT update rather than macro or global policy shift.

Alternative perspectives

Contrarian view

If investors were expecting AI-driven acceleration, UBS’s emphasis on core business could reduce enthusiasm and mute any PT-driven rally.

Overlooked factors

Near-term tape may hinge more on whether raised FY guidance and RPO momentum translate into sustained subscription growth beyond Q2.

Key entities

  • company
    MongoDB, Inc.

    Developer data platform company; subject of UBS PT change and its own quarter/guidance.

  • analyst_firm
    UBS

    Raised MDB price target to $350 from $275; maintained Neutral rating.

Read at source← All news

Related articles

JUN 5
$MDBMedAI 9/10

MongoDB Is the Latest SaaS Apocalypse Victim to Say Not Today

MongoDB shares rose nearly 40% from pre-earnings levels after the company’s blowout earnings report last week, which the article says beat expectations across key metrics and reduced concerns that AI would hurt growth. It also notes analysts raised price targets afterward, with some projecting about 20% additional upside from current levels.

finance.yahoo.com6 min
JUN 4
$SNOWLow

Snowflake vs. MongoDB: Which Technology Stock Is a Better Buy in 2026?

The article compares Snowflake (SNOW) and MongoDB (MDB) as cloud data infrastructure plays. Snowflake reported FY2026 revenue near $4.7B (+29.2%) and a net loss about $1.3B; it also cited a debt-to-equity ratio ~1.4x and free cash flow ~ $1.1B. MongoDB reported FY2026 revenue about $2.5B (+22.8%) and a net loss ~ $71.2M; it cited near-zero debt-to-equity, current ratio ~4.7x, and free cash flow ~ $500.2M.

fool.com7 min
JUN 3
$SNOWLow

Snowflake vs. MongoDB: Which Technology Stock Is a Better Buy in 2026?

The article compares Snowflake and MongoDB for 2026. Snowflake’s balance sheet (Jan 2026) shows ~0.0x debt-to-equity and a ~4.7x current ratio; free cash flow was about $500.2M, but stock-based compensation was ~109% of operating cash flow. It cites 2024 account-access issues and reliance on Amazon infrastructure. MongoDB is described as trading at lower valuation multiples, with Atlas dependence and legal uncertainty around its server-side public license.

finance.yahoo.com6 min
JUN 2
$MDBMedAI 9/10

MongoDB (MDB) Soars 20.4% as UBS Raises PT by Double-Digits

MongoDB shares rose 20.36% to close at $403.88 on Monday, extending a three-day winning streak. UBS raised its price target 27% to $350 from $275 while keeping a neutral rating. UBS cited MongoDB’s Q1 FY2027 shift to profit of $4.4M and revenue up 25% to $687.6M; MongoDB guided Q2 revenue to $729M–$734M.

finance.yahoo.com4 min
JUN 1
$MDBMedAI 9/10

MongoDB (MDB) Stock Trades Up, Here Is Why

MongoDB shares rose 17.9% in the afternoon after its May 28 earnings beat and a broader software-sector rotation, according to the article. For Q1 FY2027, revenue was $687.6M (+25% YoY) vs. $664.5M expected; adjusted EPS was $1.32 vs. $1.19. Atlas revenue grew 29.4% to $512.5M; free cash flow was $197.5M. Guidance was raised to $2.92–$2.96B revenue and $5.95–$6.14 EPS.

markets.financialcontent.com4 min
MAY 31
$SNOWMedAI 9/10

Software Was the Market's Big Laggard This Year. Snowflake's Blowout Might Be the Spark That Changes That.

Software stocks lagged early 2026 despite gains in the S&P 500, and Snowflake shares fell more than 50% from a year earlier in April. After fiscal Q1 ended April 30, Snowflake reported product revenue up 34% to $1.33B, non-GAAP operating margin rising to 12%, and EPS of $0.39. Management lifted full-year product revenue guidance to $5.84B and said AI is increasing data/workload consumption; Datadog and MongoDB also reported accelerating results.

fool.com6 min